Thursday, March 4, 2021
-9 °c
Cornwall
-12 ° Fri
-11 ° Sat
-11 ° Sun
-7 ° Mon
1 ° Tue
5 ° Wed

No products in the cart.

download our APP
  • About
    • Contributors
    • Disclaimers
    • Giving back
    • Mission Statement
    • Past Issues
    • Where to Find
    • Call us at 613-935-3763
  • Get The Seeker at Home!
  • Advertise with us!
COVID-19 Response Framework: the EOHU region is at the ORANGE-RESTRICT level.

Get the Seeker Delivered straight to your door, click here
  • Home
  • News
  • Leisure & Lifestyle
  • Community & Columnists
  • Events
    • 5 questions with…
  • Disclaimers
  • Merch
No Result
View All Result
The Seeker Newspaper Cornwall
  • Home
  • News
  • Leisure & Lifestyle
  • Community & Columnists
  • Events
    • 5 questions with…
  • Disclaimers
  • Merch
COVID-19 Response Framework: the EOHU region is at the ORANGE-RESTRICT level.

Get the Seeker Delivered straight to your door, click here
No Result
View All Result
The Seeker Newspaper Cornwall


COVID:
ORANGE
PROTECT

Home News and Announcements

COVID-19 convalescent plasma for patients

Editorial Board by Editorial Board
April 2, 2020
in News and Announcements
Reading Time: 2min read
30 2
19
SHARES
212
VIEWS

Canadian Blood Services to participate in national clinical trial

OTTAWA, April 02, 2020 (GLOBE NEWSWIRE) — Canadian Blood Services is actively working with Health Canada and the international research community to contribute to the global effort to determine if COVID-19 convalescent plasma could be an effective treatment for the coronavirus.

Canadian Blood Services is part of a team of experts representing Canada on an international working group in partnership with Australia, China, France, Germany, Italy, Singapore, South Korea, the Netherlands, the United Kingdom and the United States.

You might also like

COVID-19 Vaccines Will Soon Be Available to Adults 80 Years of Age and Older

Miller Hughes Ford Sales and Ford of Canada Donate Truck to St. Lawrence College Automotive Service Technician Program

Ontario Renews Calls for Ottawa to Provide Fair Share of Health Care Funding

In Canada, the research community has rallied together to design a national clinical trial on the use of convalescent plasma in treating the virus. An application will be submitted to Health Canada shortly. Pending approval, Canadian Blood Services and Héma-Québec will be responsible for supplying convalescent plasma to hospitals across the country.

“We have the expertise and the infrastructure necessary to collect and prepare convalescent plasma for use in a clinical trial to test its safety and effectiveness as a treatment option,” said Dr. Dana Devine, chief scientist for Canadian Blood Services. “Plasma will only be collected from volunteer donors who have fully recovered from the virus and will be used by Canadian physicians caring for patients with COVID-19 in the context of the clinical trial.”

Once the trial is underway, Canadian Blood Services will contact potential convalescent plasma donors based on defined criteria which will be approved as part of the clinical trial protocol. Convalescent plasma donors will also need to meet current Canadian Blood Services’ donor eligibility criteria. Presently, there is a small, but growing, number of people across Canada who could be eligible to participate as convalescent plasma donors in this trial.

Convalescent plasma is collected through the plasma donation process. When someone contracts a virus, their body develops antibodies against it. The antibodies remain present in their plasma to shield them from possible future infection. In theory, these antibodies could be the key ingredient for a treatment to help others with the same virus.

For more information, watch this video interview with Dr. Devine.

A national clinical trial of this size and scope will require several months to complete. In the meantime, Canadians are urged to donate blood in the next few weeks to help maintain an adequate supply of blood and blood products for patients. The need for blood is constant. Patients undergoing surgery and cancer treatment, injury victims and people living with blood disorders rely on blood products every day. To book an appointment visit blood.ca, download the GiveBlood app or call 1-888-2-DONATE (1-866-236-6283).

Author

  • Editorial Board

    View all posts

Next Post

Incorporate These Ideas For A Grand Wedding Celebration

Place YOUR ad here now
Facebook Twitter Instagram Youtube

Don't miss anything!

Get notified of all our new news by ringing the bell at the bottom right corner!

The Seeker Newspaper is located at 327 Second Street E., Cornwall, ON K6H 1Y8 -- All rights reserved
The Seeker does not accept responsibility for errors, misprints or inaccuracies published within. The opinions and statements of our columnists are not to be presumed as the statements and opinions of The Seeker
ISSN 2562-1750 (Print)

ISSN 2562-1769 (Online)
No Result
View All Result
  • Home
  • News
  • Leisure & Lifestyle
  • Community & Columnists
  • Events
    • 5 questions with…
  • Disclaimers
  • Merch

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
X
X